# Therapy of Chronic Cold Agglutinin Disease With Eculizumab

> **NCT01303952** · PHASE2 · COMPLETED · sponsor: **University Hospital, Essen** · enrollment: 13 (actual)

## Conditions studied

- Cold Agglutinin Disease

## Interventions

- **DRUG:** Eculizumab

## Key facts

- **NCT ID:** NCT01303952
- **Lead sponsor:** University Hospital, Essen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2014-09
- **Final completion:** 2015-06
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2017-07-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01303952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01303952, "Therapy of Chronic Cold Agglutinin Disease With Eculizumab". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01303952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*